Noble Financial Positive on TherapeuticsMD (TXMD) Following Investor Day
Tweet Send to a Friend
Noble Financial maintains a Buy rating and $13 target price on TherapeuticsMD (AMEX: TXMD) following the company's recent investor day.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
